Wiley Bros. Aintree Capital, LLC Takeda Pharmaceutical CO LTD Transaction History
Wiley Bros. Aintree Capital, LLC
- $14.9 Billion
- Q3 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 26,075 shares of TAK stock, worth $372,611. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,075
Previous 21,198
23.01%
Holding current value
$372,611
Previous $327,000
16.51%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TAK
# of Institutions
383Shares Held
80.6MCall Options Held
1.67MPut Options Held
276K-
Capital Research Global Investors Los Angeles, CA13.4MShares$192 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$84.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.95MShares$70.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...